[Operative Treatment of Renal Cell Carcinoma]

Overview

Journal Urologe A

Specialty Urology

Date 2011 Aug 25

PMID 21863410

Citations 1

Authors

A Heidenreich

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinoma represents the fifth most frequent malignant tumor in humans. At the time of diagnosis, 20% of the patients already manifest metastases. A further 20-30% of the patients develop systemic metastases in the postoperative course. Despite continued advances in pharmacological treatment options, cancer surgery tailored to the individual tumor findings constitutes the only curative treatment option.

Citing Articles

[Laparoscopic partial nephrectomy for renal tumors. Time for a new standard?].

Bier S, Todenhofer T, Aufderklamm S, Hennenlotter J, Mischinger J, Sim A Urologe A. 2014; 54(6):826-31.

PMID: 25297492 DOI: 10.1007/s00120-014-3656-4.

References

Kavolius J, Mastorakos D, Pavlovich C, Russo P, Burt M, Brady M . Resection of metastatic renal cell carcinoma. J Clin Oncol. 1998; 16(6):2261-6. DOI: 10.1200/JCO.1998.16.6.2261. View

Ono Y, Kinukawa T, Hattori R, Gotoh M, Kamihira O, Ohshima S . The long-term outcome of laparoscopic radical nephrectomy for small renal cell carcinoma. J Urol. 2001; 165(6 Pt 1):1867-70. DOI: 10.1097/00005392-200106000-00006. View

Siemer S, Lehmann J, Kamradt J, Loch T, Remberger K, Humke U . Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol. 2004; 171(6 Pt 1):2155-9. DOI: 10.1097/01.ju.0000125340.84492.a7. View

Miller D, Schonlau M, Litwin M, Lai J, Saigal C . Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer. 2007; 112(3):511-20. DOI: 10.1002/cncr.23218. View

Mickisch G . Principles of nephrectomy for malignant disease. BJU Int. 2002; 89(5):488-95. DOI: 10.1046/j.1464-410x.2002.02654.x. View

Portis A, Yan Y, Landman J, Chen C, Barrett P, Fentie D . Long-term followup after laparoscopic radical nephrectomy. J Urol. 2002; 167(3):1257-62. View

Wood C, Margulis V . Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease. Cancer. 2009; 115(10 Suppl):2355-60. DOI: 10.1002/cncr.24240. View

Alamdari F, Ljungberg B . Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system. Scand J Urol Nephrol. 2005; 39(4):277-82. DOI: 10.1080/003655905100077775. View

Kuczyk M, Wegener G, Jonas U . The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. Eur Urol. 2005; 48(2):252-7. DOI: 10.1016/j.eururo.2005.04.004. View

10.

Amin C, Wallen E, Pruthi R, Calvo B, Godley P, Rathmell W . Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy. Urology. 2008; 72(4):864-8. DOI: 10.1016/j.urology.2008.01.088. View

11.

Karakiewicz P, Suardi N, Jeldres C, Audet P, Ghosn P, Patard J . Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol. 2007; 53(4):845-8. DOI: 10.1016/j.eururo.2007.11.006. View

12.

Carl P, Klein U, GEBAUER A, SCHMIEDT E . The value of lymphography for the TNM classification of renal carcinoma. Eur Urol. 1977; 3(5):286-8. DOI: 10.1159/000472117. View

13.

Crepel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat S . Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. Urology. 2009; 75(2):271-5. DOI: 10.1016/j.urology.2009.04.098. View

14.

Flanigan R, Mickisch G, Sylvester R, Tangen C, van Poppel H, Crawford E . Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol. 2004; 171(3):1071-6. DOI: 10.1097/01.ju.0000110610.61545.ae. View

15.

Saika T, Ono Y, Hattori R, Gotoh M, Kamihira O, Yoshikawa Y . Long-term outcome of laparoscopic radical nephrectomy for pathologic T1 renal cell carcinoma. Urology. 2003; 62(6):1018-23. DOI: 10.1016/j.urology.2003.07.009. View

16.

Ito A, Satoh M, Ohyama C, Saito S, Shintaku I, Nakano O . Adrenal metastasis from renal cell carcinoma: significance of adrenalectomy. Int J Urol. 2002; 9(3):125-8. DOI: 10.1046/j.1442-2042.2002.00442.x. View

17.

Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

18.

Ohlmann C, Ozgur E, Schrader A, Konrad L, Hofmann R, Engelmann U . Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: results of a prospective trial. Urol Oncol. 2006; 24(4):287-93. DOI: 10.1016/j.urolonc.2005.10.004. View

19.

Chan D, Cadeddu J, Jarrett T, Marshall F, Kavoussi L . Laparoscopic radical nephrectomy: cancer control for renal cell carcinoma. J Urol. 2001; 166(6):2095-9; discussion 2099-100. DOI: 10.1016/s0022-5347(05)65513-9. View

20.

Studer U, Scherz S, Scheidegger J, Kraft R, SONNTAG R, Ackermann D . Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol. 1990; 144(2 Pt 1):243-5. DOI: 10.1016/s0022-5347(17)39422-3. View